Our data show that the previously proposed hs-cTnT cutoffs of 14 ng/L and 28.6 ng/L are inadequate for excluding ATTRv-CM in TTRv carriers with or without amyloidosis. The gene discussed is TNNT2; the disease is amyloidosis.